First Generic EpiPen Gets FDA Approval
The US Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children.
Watch CBS News
The US Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children.
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.
President Donald Trump and Maryland Congressman Elijah Cummings came together to combat sky-high prescrption drug costs.
CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price.
There is renewed outrage over the astronomical costs of life-saving prescription drugs and how families are coping with the cost.
EpiPen manufacturer Mylan's CEO was on the hot seat Wednesday in Capitol Hill due to nationwide outcry over skyrocketing EpiPen prices.
Sky-high price hikes for EpiPen have made its maker the latest target for patients and politicians infuriated by soaring drug prices.
Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.
The costs are dramatically rising for a life-saving drug millions of people with severe allergies depend on.
CBS 2's Mary Kay Kleist reports, researchers at Lurie Children's Hospital are conducting a study that may give patients other options in the future. But does it work?
